Skip to main content

Lucira Health SARS-CoV-2 Self-Test Receives Health Canada Conditional Authorization

NEW YORK – Lucira Health announced on Monday that the Lucira Check It COVID-19 test kit received an Authorization with Conditions from Health Canada.

The authorization was granted under Health Canada's Interim Order, which allows COVID-19 products that might not fully meet Canadian regulatory requirements to be imported and sold if they're manufactured to comparable standards.

The loop-mediated isothermal amplification test can deliver results in 30 minutes or less and will be available for Canadians to buy online in June for around C$75 (US$60), the company said in a statement. Lucira added that its kit is the first self-test authorized by Health Canada for people with or without symptoms.

Lucira's test can determine a positive result within 11 minutes or confirm a negative result within 30 minutes and doesn't require a prescription or supervised assistance to perform. Earlier this month, the test received Emergency Use Authorization from the US Food and Drug Administration for over-the-counter use at home. It previously received a separate EUA in November for prescription use under the name Lucira COVID-19 All-In-One Test Kit.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.